Wang, S., Shiboski, S., Belair, C. D., Cooperberg, M. R., Simko, J. P., Stoppler, H., . . . Blelloch, R. (2014). miR-19, miR-345, miR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance. Public Library of Science.

Wang, Siao-Yi, Stephen Shiboski, Cassandra D. Belair, Matthew R. Cooperberg, Jeffrey P. Simko, Hubert Stoppler, Janet Cowan, Peter R. Carroll, e Robert Blelloch. MiR-19, MiR-345, MiR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance. Public Library of Science, 2014.

Wang, Siao-Yi, et al. MiR-19, MiR-345, MiR-519c-5p Serum Levels Predict Adverse Pathology in Prostate Cancer Patients Eligible for Active Surveillance. Public Library of Science, 2014.